Clevidipine Side Effects
Some side effects of clevidipine may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
For the Consumer
Applies to clevidipine: intravenous emulsion
Get emergency medical help if you have any of these signs of an allergic reaction while taking clevidipine: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Tell your caregiver at once if you have a serious side effect such as:
-
feeling like you might pass out;
-
rapid heart rate;
-
urinating less than usual or not at all;
-
weakness, confusion, increased thirst, loss of appetite, vomiting, pounding heartbeats or fluttering in your chest;
-
swelling, weight gain, feeling short of breath;
-
vomiting, diarrhea, stomach cramps, bloating, severe constipation;
-
chest pain or heavy feeling, pain spreading to the arm or shoulder, sweating, general ill feeling;
-
slow heart rate, weak pulse, fainting, slow breathing (breathing may stop); or
-
dangerously high blood pressure (severe headache, blurred vision, buzzing in your ears, anxiety, confusion, chest pain, uneven heartbeats, seizure).
Less serious side effects of clevidipine may include:
-
mild headache;
-
mild nausea; or
-
mild constipation.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.
For Healthcare Professionals
Applies to clevidipine: intravenous emulsion
Cardiovascular
Cardiovascular side effects have included atrial fibrillation (up to 21%), myocardial infarction (less than 1%), cardiac arrest (less than 1%), systemic hypotension, and reflex tachycardia. Hypotension and reflex tachycardia have been reported during postmarketing experience.
Gastrointestinal
Gastrointestinal side effects have included nausea (up to 21%) and vomiting (3.2%). Ileus and nausea have been reported during postmarketing experience.
Renal
Renal side effects have included acute renal failure (up to 9%).
Nervous system
Nervous system side effects have included headache (6.3%) and syncope (less than 1%).
Respiratory
Respiratory side effects have included dyspnea (less than 1%).
Other
Other side effects have included decreased oxygen saturation (possible pulmonary shunting) during postmarketing experience.
Metabolic
Metabolic side effects have included increased blood triglycerides during postmarketing experience.
Hypersensitivity
Hypersensitivity side effects have included hypersensitivity during postmarketing experience.
More clevidipine resources
- clevidipine MedFacts Consumer Leaflet (Wolters Kluwer)
- clevidipine Intravenous Advanced Consumer (Micromedex) - Includes Dosage Information
- Clevidipine Butyrate Monograph (AHFS DI)
- Cleviprex Prescribing Information (FDA)
- Cleviprex Consumer Overview
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.


